WeForNews | Latest News, Breaking News, News Updates Did Satoshi Nakamoto Predict The Outbreak of COVID-19 In Bitcoin’s Whitepaper Back In 2008? | WeForNews | Latest News, Blogs
Connect with us

Blog

Did Satoshi Nakamoto Predict The Outbreak of COVID-19 In Bitcoin’s Whitepaper Back In 2008?

Published

on

OCD and Coronavirus COVID 19

The novel coronavirus (COVID-19) took the world by a storm and its spread, and it shows no signs of slowing down. With the total number of infected people getting close to a million, countries around the world are instituting lockdowns to slow down the spread and keep the hospitals from overflowing with patients.

A closer look at Bitcoin’s whitepaper, however, reveals that its pseudonymous creator, Satoshi Nakamoto, had the foresight to create a system that’s effective in situations much like the current one. Could it be that he actually predicted the current pandemic?

Satoshi Nakamoto Predicting COVID in Bitcoin’s Whitepaper in 2008
In 2008, a pseudonymous entity published what would soon become a landmark whitepaper called Bitcoin: A Peer to Peer Electronic Cash System. In it, he describes a system that enables the transfer of wealth almost instantly from one party to another without the need for intermediaries.

However, a closer look at the document reveals that Satoshi Nakamoto actually had a scenario of the kind in mind and designed the system so that it could be sustainable even in such black swan events.

btc_wp_2020v

Of course, his words are entirely open to interpretation, and it’s possible that he might have been inspired by previous outbreaks of deadly viruses to which humankind is no stranger.

Still, it’s particularly interesting to see his creation handling the current situation the way it does. It’s true that Bitcoin declined in price substantially throughout the past month, and most of it was caused by panic selling likely catalyzed by the growing fears of the spreading virus and its impact on the global economy.

However, it’s also worth noting that Bitcoin, unlike legacy markets, has no one to safeguard it. There are no emergency circuit breakers, and there is no government to print trillions of dollars to patch the holes in the markets.

COVID-19: A Growing Concern

What started in China a few months ago has now transitioned throughout the entire world as the COVID-19 coronavirus has infected just shy of 900,000 people. Out of those, 44,201 have unfortunately lost their lives while 185,204 recovered, according to data at the time of this writing.

All of that becomes even more worrisome upon closer inspection of the closed cases. Out of 229,405 cases with an outcome, 44,201 people died. That’s 19%. 185,204 people have recovered and have been discharged.

What most scientific experts are worried about is the rapid growth in the numbers of affected people and the lack of resources to handle those cases.

coronavirus_cases

Hence, many countries across the world have instituted either mandatory or recommended lockdowns in hopes to prevent the exponential growth of the virus so that hospitals don’t get overflown with patients they can’t possibly treat to the highest of standards.

Nevertheless, positivity comes from China – the country where the virus originally appeared. In the past few weeks, the cases in the country are virtually non-existent, hinting that the countermeasures they applied produced the intended results.

Disclaimer: the part about Satoshi Nakamoto predicting the outbreak of COVID is entirely fictional and intended as a comic April Fools’ joke. The image used in the article was intentionally fabricated, and the highlighted text doesn’t exist in the original whitepaper

Blog

Male sex hormones may help treat breast cancer: Study

While endocrine therapy is standard-of-care for estrogen receptor positive breast cancer, resistance to these drugs is the major cause of breast cancer mortality.

Published

on

By

breast cancer

Sydney : Researchers have found new evidence about the positive role of androgens, commonly thought of as male sex hormones but also found at lower levels in women, in breast cancer treatment.

In normal breast development, estrogen stimulates and androgen inhibits growth at puberty and throughout adult life.

Abnormal estrogen activity is responsible for the majority of breast cancers, but the role of androgen activity in this disease has been controversial.

The new research published in the journal Nature Medicine showed that androgens have potential for treatment of estrogen receptor positive breast cancer.

A cancer is called estrogen receptor positive if it has receptors for estrogen, according to Breastcancer.org.

Using cell-line and patient-derived models, the global team, including researchers at the University of Adelaide and the Garvan Institute of Medical Research in Australia, demonstrated that androgen receptor activation by natural androgen or a new androgenic drug had potent anti-tumour activity in all estrogen receptor positive breast cancers, even those resistant to current standard-of-care treatments.

In contrast, androgen receptor inhibitors had no effect.

“This work has immediate implications for women with metastatic estrogen receptor positive breast cancer, including those resistant to current forms of endocrine therapy,” said lead researcher Theresa Hickey, Associate Professor at the University of Adelaide.

“We provide compelling new experimental evidence that androgen receptor stimulating drugs can be more effective than existing (e.g. Tamoxifen) or new (e.g. Palbociclib) standard-of-care treatments and, in the case of the latter, can be combined to enhance growth inhibition,” said Wayne Tilley, Director of the Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide.

Androgens were historically used to treat breast cancer, but knowledge of hormone receptors in breast tissue was rudimentary at the time and the treatment’s efficacy misunderstood.

Androgen therapy was discontinued due to virilising side effects and the advent of anti-estrogenic endocrine therapies.

While endocrine therapy is standard-of-care for estrogen receptor positive breast cancer, resistance to these drugs is the major cause of breast cancer mortality.

“The new insights from this study should clarify the widespread confusion over the role of the androgen receptor in estrogen receptor driven breast cancer,” said Elgene Lim, a breast oncologist and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute.

“Given the efficacy of this treatment strategy at multiple stages of disease in our study, we hope to translate these findings into clinical trials as a new class of endocrine therapy for breast cancer.”

Continue Reading

Blog

Azim Premji and Dr Devi Shetty chosen for PCB awards

Besides them 25 senior journalists have been selected for the ‘Press Club Annual Awards’, a release said.

Published

on

By

Azim Premji Wipro

Bengaluru, Jan 19: The chairman of Wipro Limited Azim Premji and the founder chairman of Narayana Health Dr Devi Prasad Shetty are among those who have been selected for the annual awards given by the Press Club of Bangalore.

Premji has been chosen for ‘Press Club Person of the Year’, while Dr Shetty and actor-Director Sudeep Sanjeev have been selected for the ‘Press Club Special Award.’

Besides them 25 senior journalists have been selected for the ‘Press Club Annual Awards’, a release said.

Chief Minister B S Yediyurappa will facilitate the awardees at a function scheduled for the third week of February, it said.

Continue Reading

Blog

Elizabeth Olsen: Nepotism creates fear that you don’t deserve the work you get

The actress added that she “always had this need to prove myself to everyone around me that I work really hard”, adding: “I couldn’t walk in a room without everyone already having an opinion.”

Published

on

By

Elizabeth Olsen

Los Angeles, Jan 19 : Hollywood star Elizabeth Olsen says she once thought of changing her surname and distance herself from the success of her family because it was insanity growing up in the spotlight.

“It was insanity. There were times when my sisters would always be spotted and I would be in the car with them and it would really freak me out. It has helped me navigate how I want to approach my career,” said the actress, whose older sisters are Mary-Kate Olsen and Ashley Olsen.

The actress added that she “always had this need to prove myself to everyone around me that I work really hard”, adding: “I couldn’t walk in a room without everyone already having an opinion.”

Elizabeth opened up om the fears of nepotism.

“The thing about nepotism is the fear that you don’t earn or deserve the work. There was even a part of me when I was a little girl that thought if I’m gonna be an actress I’m going to go by Elizabeth Chase, which is my middle name. And then, once I started working, I was like, ‘I love my family, I like my name, I love my sisters. Why would I be so ashamed of that?’ It’s fine now,” she said.

The actress said fame has made her more of a homebody.

“Fame has also made me someone who is more of a homebody than maybe I would like to be but I know where not to go. If I could do whatever I wanted for the day, I’d start with the gym, then I’d go to the grocery store, because it’s my favourite thing,” Elizabeth told The Sun.

Continue Reading
Advertisement

Most Popular